Tumour Marker | List of Frontiers open access articles

Original Research

Published on 29 Jan 2020

Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases

in Alzheimer's Disease and Related Dementias

Shunjie Liu
Zhenze Huang
Lijin Zhang
Junhao Pan
Qingfeng Lei
Yangyang Meng
Zhong Li

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00010

5,750 views
17 citations

Review

Published on 09 Jan 2026

Application of surface-enhanced Raman spectroscopy in the diagnosis and treatment of breast cancer

in Precision Medicine

Xin-Xin Luo
Meng-Ye He
Meng-Li Luo
Yun-Lu Jia
Peng Shen

Frontiers in Medicine

doi 10.3389/fmed.2025.1725221

645 views

Study Protocol

Published on 12 Apr 2021

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

in Personalized Medicine

Benjamin Kye Jyn Tan
Chong Boon Teo
Xavier Tadeo
Siyu Peng
Hazel Pei Lin Soh
Sherry De Xuan Du
Vilianty Wen Ya Luo
Aishwarya Bandla
Raghav Sundar
Dean Ho

Frontiers in Digital Health

doi 10.3389/fdgth.2021.635524

9,656 views
37 citations

Systematic Review

Published on 08 Oct 2021

Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance

in Cancer Endocrinology

Carina Bernardo
Fátima L. Monteiro
Inês Direito
Francisco Amado
Vera Afreixo
Lúcio L. Santos
Luisa A. Helguero

Frontiers in Endocrinology

doi 10.3389/fendo.2021.684140

9,184 views
14 citations

Review

Published on 11 Jun 2024

Critically evaluated key points on hereditary medullary thyroid carcinoma

in Thyroid Endocrinology

Daqi Zhang
Nan Liang
Hui Sun
Francesco Frattini
Chengqiu Sui
Mingyu Yang
Hongbo Wang
Gianlorenzo Dionigi

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1412942

3,799 views
7 citations

Original Research

Published on 25 Aug 2021

A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients

in RNA

Samantha Peiling Yang
Lian Chye Winston Koh
Kiat Whye Kong
Rajeev Parameswaran
Kelvin Siu Hoong Loke
Kee Yuan Ngiam
Wee Boon Tan
Thomas Loh
David Chee Eng Ng
Boon Cher Goh

Frontiers in Genetics

doi 10.3389/fgene.2021.721832

4,692 views
5 citations

Methods

Published on 19 May 2022

Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma

in Molecular Diagnostics and Therapeutics

Zarwa Yaseen
Tuba N. Gide
Jordan W. Conway
Alison J. Potter
Camelia Quek
Angela M. Hong
Georgina V. Long
Richard A. Scolyer
James S. Wilmott

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2022.810858

11,749 views
29 citations

Original Research

Published on 18 Oct 2022

Blood–brain barrier and brain structural changes in lung cancer patients with non-brain metastases

in Cancer Imaging and Image-directed Interventions

Da-Fu Zhang
Huan Ma
Guang-Jun Yang
Zhi-Ping Zhang
Yin-Fu He
Mao-Yang Feng
Bao-Ci Shan
Xiu-Feng Xu
Ying-Ying Ding
Yu-Qi Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.1015011

3,893 views
4 citations

Articles

Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases

Application of surface-enhanced Raman spectroscopy in the diagnosis and treatment of breast cancer

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance

Critically evaluated key points on hereditary medullary thyroid carcinoma

A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients

Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma

Blood–brain barrier and brain structural changes in lung cancer patients with non-brain metastases